TickerFacts.

A business in context

EBS research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-18 · 0001367644-26-000088 · Items 8.01,9.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001367644-26-000082

  3. 8-K · Current report

    Report date 2026-08-05 · 0001367644-26-000080 · Items 2.02,2.05,5.02,7.01,9.01

  4. 4 · Ownership change

    Report date 2026-07-01 · 0001961994-26-000024

  5. 8-K · Current report

    Report date 2026-06-26 · 0001367644-26-000068 · Items 1.01,7.01,9.01

  6. 4 · Ownership change

    Report date 2026-06-08 · 0001989644-26-000011

  7. 4 · Ownership change

    Report date 2026-06-08 · 0001961994-26-000021

  8. 4 · Ownership change

    Report date 2026-06-08 · 0001919170-26-000016

  9. 4 · Ownership change

    Report date 2026-06-08 · 0001196632-26-000017

  10. 4 · Ownership change

    Report date 2026-04-30 · 0001685720-26-000003

  11. 4 · Ownership change

    Report date 2026-04-30 · 0001583098-26-000004

  12. 4 · Ownership change

    Report date 2026-04-30 · 0001536908-26-000004

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001367644-26-000065

  14. 8-K · Current report

    Report date 2026-04-30 · 0001367644-26-000059 · Items 2.02,7.01,9.01

  15. 8-K · Current report

    Report date 2026-04-29 · 0001367644-26-000051 · Items 5.07,9.01

  16. 8-K · Current report

    Report date 2026-04-16 · 0001367644-26-000038 · Items 1.01,1.02,3.02,7.01,9.01

  17. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0001367644-26-000033

  18. 8-K · Current report

    Report date 2026-02-25 · 0001367644-26-000019 · Items 5.02,7.01,9.01

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001367644-26-000015

  20. 8-K · Current report

    Report date 2026-02-26 · 0001367644-26-000012 · Items 2.02,7.01,9.01

  21. 8-K · Current report

    Report date 2026-01-14 · 0001193125-26-013061 · Items 7.01,9.01

  22. 8-K · Current report

    Report date 2026-01-12 · 0001367644-26-000003 · Items 7.01,9.01

  23. 8-K · Current report

    Report date 2025-12-12 · 0001367644-25-000207 · Items 7.01,9.01

  24. 8-K · Current report

    Report date 2025-11-07 · 0001367644-25-000204 · Items 5.02,7.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001367644-25-000202

  26. 8-K · Current report

    Report date 2025-10-29 · 0001367644-25-000198 · Items 2.02,7.01,9.01

  27. 8-K · Current report

    Report date 2025-09-05 · 0001367644-25-000188 · Items 1.01,7.01,9.01

  28. 8-K · Current report

    Report date 2025-09-02 · 0001367644-25-000183 · Items 8.01,9.01

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001367644-25-000181

  30. 8-K · Current report

    Report date 2025-08-06 · 0001367644-25-000179 · Items 2.02,7.01,9.01

  31. 8-K · Current report

    Report date 2025-06-23 · 0001367644-25-000153 · Items 8.01,9.01

  32. 8-K · Current report

    Report date 2025-05-23 · 0001367644-25-000133 · Items 8.01,9.01

  33. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001367644-25-000124

  34. 8-K · Current report

    Report date 2025-05-07 · 0001367644-25-000121 · Items 2.02,7.01,9.01

  35. 8-K · Current report

    Report date 2025-04-30 · 0001367644-25-000114 · Items 5.07,9.01

  36. 8-K · Current report

    Report date 2025-03-31 · 0001367644-25-000087 · Items 8.01,9.01

  37. 8-K · Current report

    Report date 2025-03-19 · 0001367644-25-000083 · Items 8.01

  38. DEF 14A · Proxy statement

    Report date 2024-12-31 · 0001367644-25-000080

  39. 8-K · Current report

    Report date 2025-03-10 · 0001367644-25-000054 · Items 7.01,8.01,9.01

  40. 10-K · Annual report

    Report date 2024-12-31 · 0001367644-25-000021

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 8 transaction rows8SGrant / award: 25 transaction rows25AExercise / conversion: 0 transaction rows0MTax / exercise payment: 4 transaction rows4FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

37 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-08
2026-06-10
Hartzel WilliamF · Tax / exercise payment
Disposed
Common Stock1741.08.0
2026-06-08
2026-06-10
Williams Paul AnthonyF · Tax / exercise payment
Disposed
Common Stock694.08.0
2026-06-08
2026-06-10
Glessner ColeenF · Tax / exercise payment
Disposed
Common Stock2018.08.0
2026-06-08
2026-06-10
LINDAHL RICHARD SF · Tax / exercise payment
Disposed
Common Stock3964.08.0
2026-05-01
2026-05-04
Zoon Kathryn C
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1057.08.97
2026-05-01
2026-05-04
Zoon Kathryn C
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock16145.08.36
2026-05-01
2026-05-04
DeGolyer Donald W
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock954.08.96
2026-05-01
2026-05-04
DeGolyer Donald W
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock14527.08.36
2026-05-01
2026-05-04
Dayal Sujata Tyagi
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock980.08.94
2026-05-01
2026-05-04
Dayal Sujata Tyagi
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock12781.08.36
2026-04-30
2026-05-04
Zoon Kathryn C
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock25344.00.0
2026-04-30
2026-05-04
Zoon Kathryn C
10b5-1 checkbox reported
A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
11296.00.0
2026-04-30
2026-05-04
DeGolyer Donald W
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock25344.00.0
2026-04-30
2026-05-04
DeGolyer Donald W
10b5-1 checkbox reported
A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
11296.00.0
2026-04-30
2026-05-04
Dayal Sujata Tyagi
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock25344.00.0
2026-04-30
2026-05-04
Dayal Sujata Tyagi
10b5-1 checkbox reported
A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
11296.00.0
2026-04-30
2026-05-04
Fowler Neal FranklinA · Grant / award
Acquired
Common Stock25344.00.0
2026-04-30
2026-05-04
Fowler Neal FranklinA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
11296.00.0
2026-04-30
2026-05-04
White Marvin LA · Grant / award
Acquired
Common Stock25344.00.0
2026-04-30
2026-05-04
White Marvin LA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
11296.00.0
2026-04-30
2026-05-04
Harsanyi ZsoltA · Grant / award
Acquired
Common Stock25344.00.0
2026-04-30
2026-05-04
Harsanyi ZsoltA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
11296.00.0
2026-04-30
2026-05-04
Richard RonaldA · Grant / award
Acquired
Common Stock25344.00.0
2026-04-30
2026-05-04
Richard RonaldA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
11296.00.0
2026-04-30
2026-05-04
Katkin Keith
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock25344.00.0
2026-04-30
2026-05-04
Katkin Keith
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock15481.08.28
2026-04-30
2026-05-04
Katkin Keith
10b5-1 checkbox reported
A · Grant / award
Acquired
Stock Options (Right to Buy)
Derivative security
11296.00.0
2026-04-30
2026-05-04
FOWLER JOHN D JRA · Grant / award
Acquired
Common Stock25344.00.0
2026-04-30
2026-05-04
FOWLER JOHN D JRA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
11296.00.0
2026-04-29
2026-05-01
Lowry Simon CA · Grant / award
Acquired
Common Stock100111.00.0
2026-04-29
2026-05-01
Perl JessicaA · Grant / award
Acquired
Common Stock104282.00.0
2026-04-29
2026-05-01
Hartzel WilliamA · Grant / award
Acquired
Common Stock100111.00.0
2026-04-29
2026-05-01
Williams Paul AnthonyA · Grant / award
Acquired
Common Stock100111.00.0
2026-04-29
2026-05-01
Glessner ColeenA · Grant / award
Acquired
Common Stock100111.00.0
2026-04-29
2026-05-01
PAPA JOSEPH CA · Grant / award
Acquired
Common Stock187708.00.0
2026-04-29
2026-05-01
LINDAHL RICHARD SA · Grant / award
Acquired
Common Stock162680.00.0
2026-04-01
2026-04-03
Williams Paul Anthony
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4000.08.44

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001367644Emergent BioSolutions Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$1.04B$1.11B
    2023-12-31$1.05B$1.15B
    2022-12-31$1.12B$1.27B
    2021-12-31$1.77B$2.19B
    2020-12-31$1.58B$2.04B
    2019-12-31$1.11B$1.44B

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗